Introducing PharmAlliance International Labs’ Amlodipine as Besylate Tablets

Company Introduction:

Welcome to PharmAlliance International Labs Private Limited, a beacon of excellence in the realm of healthcare, dedicated to crafting superior medications for enhanced patient well-being. It is with great pleasure that we unveil our latest innovation: Amlodipine as Besylate Tablets, meticulously formulated to tackle hypertension and a spectrum of cardiovascular conditions with unparalleled efficacy.

Drug Classification:

Amlodipine as Besylate Tablets falls under the esteemed category of calcium channel blockers, revered for their ability to modulate vascular tone and blood pressure regulation. This class of medications operates by selectively inhibiting calcium influx into smooth muscle cells, fostering vasodilation and optimizing blood flow dynamics.

Formulations:

Our Amlodipine as Besylate Tablets is available in two potencies: 5mg and 10mg, encapsulating precision and potency in convenient oral tablets. Each blister pack contains 20 tablets, meticulously designed to cater to the diverse needs of our patients worldwide.

Indications:

Amlodipine as Besylate Tablets serves as a cornerstone in the management of various cardiovascular conditions, including:

Hypertension: Effectively lowering blood pressure and mitigating the risk of debilitating cardiovascular events such as stroke and heart attack.

Chronic Stable Angina: Enhancing exercise tolerance and reducing the frequency of angina attacks, empowering patients to lead active, fulfilling lives.

Usage:

To unlock the full therapeutic potential of Amlodipine as Besylate Tablets, adherence to the prescribed dosage and administration regimen is paramount. These tablets should be taken orally once daily, with or without food, under the guidance of a healthcare professional.

Dosage:

For most patients grappling with hypertension or angina, the recommended starting dose is 5mg once daily, with individual adjustments tailored to response and tolerability. The maximum dose for hypertension is 10mg once daily, and for angina, it’s also 10mg once daily.

Pharmacokinetics:

Following oral administration, Amlodipine exhibits rapid absorption, with peak plasma concentrations achieved within 6 to 12 hours. Hepatic metabolism predominates, with the majority of the drug excreted in urine as metabolites. With an elimination half-life of approximately 30 to 50 hours, once-daily dosing ensures consistent blood pressure control.

Pharmacodynamics:

Amlodipine orchestrates its therapeutic effects by selectively antagonizing calcium influx through voltage-sensitive L-type calcium channels in vascular smooth muscle cells. This mechanism engenders peripheral vasodilation, curbing systemic vascular resistance, and heralding blood pressure reduction sans compromise to heart rate or cardiac conduction.

Side Effects:

While generally well-tolerated, Amlodipine as Besylate Tablets may induce peripheral edema, headache, dizziness, and fatigue. Vigilance is warranted, as rare but serious adverse effects like hypotension and bradycardia necessitate prompt medical intervention.

Experience the unmatched efficacy and safety of Amlodipine for hypertension and angina management, exclusively from PharmAlliance International Labs. For further inquiries or information, please don’t hesitate to reach out. Your cardiovascular health is our utmost priority, and we remain steadfast in our commitment to delivering optimal patient care.